According to Lambert et al. [82], GLP-1 has been shown to improve insulin sensitivity and reduce hepatic glucose production in the animal model of NAFLD, which inhibits the development of liver steatosis, NASH, and liver fibrosis. The gene discussed is INS; the disease is Hepatic steatosis.